Logo image of EXPI

EXP WORLD HOLDINGS INC (EXPI) Stock Fundamental Analysis

NASDAQ:EXPI - Nasdaq - US30212W1009 - Common Stock - Currency: USD

8.8  +0.07 (+0.8%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to EXPI. EXPI was compared to 65 industry peers in the Real Estate Management & Development industry. EXPI has a great financial health rating, but its profitability evaluates not so good. EXPI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year EXPI has reported negative net income.
EXPI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EXPI reported negative net income in multiple years.
In the past 5 years EXPI always reported a positive cash flow from operatings.
EXPI Yearly Net Income VS EBIT VS OCF VS FCFEXPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

EXPI has a Return On Assets (-3.90%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -8.03%, EXPI is in line with its industry, outperforming 49.23% of the companies in the same industry.
The Return On Invested Capital of EXPI (4.70%) is better than 73.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXPI is below the industry average of 5.45%.
The 3 year average ROIC (3.18%) for EXPI is below the current ROIC(4.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -3.9%
ROE -8.03%
ROIC 4.7%
ROA(3y)-1.22%
ROA(5y)5.76%
ROE(3y)-2.57%
ROE(5y)10.16%
ROIC(3y)3.18%
ROIC(5y)7.72%
EXPI Yearly ROA, ROE, ROICEXPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

EXPI has a Operating Margin (0.28%) which is in line with its industry peers.
In the last couple of years the Operating Margin of EXPI has declined.
Looking at the Gross Margin, with a value of 7.43%, EXPI is doing worse than 76.92% of the companies in the same industry.
In the last couple of years the Gross Margin of EXPI has declined.
Industry RankSector Rank
OM 0.28%
PM (TTM) N/A
GM 7.43%
OM growth 3Y-21.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
EXPI Yearly Profit, Operating, Gross MarginsEXPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXPI is destroying value.
EXPI has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EXPI has been increased compared to 5 years ago.
There is no outstanding debt for EXPI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXPI Yearly Shares OutstandingEXPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EXPI Yearly Total Debt VS Total AssetsEXPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 14.18 indicates that EXPI is not in any danger for bankruptcy at the moment.
EXPI has a better Altman-Z score (14.18) than 93.85% of its industry peers.
EXPI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.18
ROIC/WACC0.52
WACC9.1%
EXPI Yearly LT Debt VS Equity VS FCFEXPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

EXPI has a Current Ratio of 1.34. This is a normal value and indicates that EXPI is financially healthy and should not expect problems in meeting its short term obligations.
EXPI has a Current ratio (1.34) which is comparable to the rest of the industry.
A Quick Ratio of 1.34 indicates that EXPI should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.34, EXPI perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
EXPI Yearly Current Assets VS Current LiabilitesEXPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.11% over the past year.
EXPI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.71%.
EXPI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.05% yearly.
EPS 1Y (TTM)11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%1.26%

3.2 Future

EXPI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 239.41% yearly.
The Revenue is expected to grow by 6.93% on average over the next years.
EPS Next Y508%
EPS Next 2Y239.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.44%
Revenue Next 2Y6.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EXPI Yearly Revenue VS EstimatesEXPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
EXPI Yearly EPS VS EstimatesEXPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

EXPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 30.81 indicates a quite expensive valuation of EXPI.
EXPI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXPI is cheaper than 72.31% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.17. EXPI is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 30.81
EXPI Price Earnings VS Forward Price EarningsEXPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXPI indicates a somewhat cheap valuation: EXPI is cheaper than 61.54% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, EXPI is valued cheaper than 90.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.51
EV/EBITDA 60.75
EXPI Per share dataEXPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

EXPI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPI's earnings are expected to grow with 239.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y239.41%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

EXPI has a Yearly Dividend Yield of 2.36%.
Compared to an average industry Dividend Yield of 3.60, EXPI pays a better dividend. On top of this EXPI pays more dividend than 90.77% of the companies listed in the same industry.
EXPI's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.36%

5.2 History

EXPI has been paying a dividend for over 5 years, so it has already some track record.
EXPI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
EXPI Yearly Dividends per shareEXPI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

The earnings of EXPI are negative and hence is the payout ratio. EXPI will probably not be able to sustain this dividend level.
DP-176.32%
EPS Next 2Y239.41%
EPS Next 3YN/A
EXPI Yearly Income VS Free CF VS DividendEXPI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

More info and screens

EXP WORLD HOLDINGS INC

NASDAQ:EXPI (6/5/2025, 10:28:57 AM)

8.8

+0.07 (+0.8%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners42.02%
Inst Owner Change0.53%
Ins Owners47.41%
Ins Owner Change-0.84%
Market Cap1.37B
Analysts80
Price Target15.05 (71.02%)
Short Float %21.45%
Short Ratio12.77
Dividend
Industry RankSector Rank
Dividend Yield 2.36%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP-176.32%
Div Incr Years3
Div Non Decr Years3
Ex-Date05-19 2025-05-19 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-440.4%
Min EPS beat(2)-928.9%
Max EPS beat(2)48.1%
EPS beat(4)1
Avg EPS beat(4)-275.84%
Min EPS beat(4)-928.9%
Max EPS beat(4)48.1%
EPS beat(8)2
Avg EPS beat(8)-166.91%
EPS beat(12)3
Avg EPS beat(12)-118.9%
EPS beat(16)7
Avg EPS beat(16)-38.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-5.92%
Max Revenue beat(2)4.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.25%
Min Revenue beat(4)-5.92%
Max Revenue beat(4)4.39%
Revenue beat(8)5
Avg Revenue beat(8)-0.2%
Revenue beat(12)5
Avg Revenue beat(12)-2.14%
Revenue beat(16)9
Avg Revenue beat(16)1.58%
PT rev (1m)0%
PT rev (3m)-6.35%
EPS NQ rev (1m)-16.22%
EPS NQ rev (3m)-16.22%
EPS NY rev (1m)-29.41%
EPS NY rev (3m)-60.87%
Revenue NQ rev (1m)-2.83%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)-1.78%
Revenue NY rev (3m)-3.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.81
P/S 0.3
P/FCF 8.51
P/OCF 8.04
P/B 6.48
P/tB 7.28
EV/EBITDA 60.75
EPS(TTM)-0.08
EYN/A
EPS(NY)0.29
Fwd EY3.25%
FCF(TTM)1.03
FCFY11.76%
OCF(TTM)1.09
OCFY12.44%
SpS29.32
BVpS1.36
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.9%
ROE -8.03%
ROCE 5.94%
ROIC 4.7%
ROICexc 4.7%
ROICexgc 5.27%
OM 0.28%
PM (TTM) N/A
GM 7.43%
FCFM 3.53%
ROA(3y)-1.22%
ROA(5y)5.76%
ROE(3y)-2.57%
ROE(5y)10.16%
ROIC(3y)3.18%
ROIC(5y)7.72%
ROICexc(3y)6.95%
ROICexc(5y)19.72%
ROICexgc(3y)9.37%
ROICexgc(5y)31.83%
ROCE(3y)4.03%
ROCE(5y)9.78%
ROICexcg growth 3Y-5.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y-8.74%
ROICexc growth 5YN/A
OM growth 3Y-21.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
F-Score6
Asset Turnover10.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 95.79%
Cap/Sales 0.21%
Interest Coverage 250
Cash Conversion 761.9%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 14.18
F-Score6
WACC9.1%
ROIC/WACC0.52
Cap/Depr(3y)91.01%
Cap/Depr(5y)129.14%
Cap/Sales(3y)0.21%
Cap/Sales(5y)0.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250%
EPS Next Y508%
EPS Next 2Y239.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.71%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%1.26%
Revenue Next Year4.44%
Revenue Next 2Y6.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y267%
EBIT growth 3Y-16.38%
EBIT growth 5YN/A
EBIT Next Year404.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.44%
FCF growth 3Y-7.61%
FCF growth 5Y29.74%
OCF growth 1Y10.25%
OCF growth 3Y-8.04%
OCF growth 5Y28.31%